Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Operating Expenses | 7,430 | 5,510 | 2,850 | 3,150 | 2,810 |
| Operating Income | -7,430 | -5,510 | -2,850 | -3,150 | -2,810 |
| Other Income | 0 | -10 | -10 | 30 | -10 |
| Pre-tax Income | -7,430 | -5,520 | -2,860 | -3,120 | -2,820 |
| Net Income Continuous | -7,439 | -5,522 | -2,868 | -3,114 | -2,821 |
| Net Income | $-7,439 | $-5,522 | $-2,868 | $-3,114 | $-2,821 |
| EPS Basic Total Ops | -0.09 | -0.10 | -0.16 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -0.09 | -0.07 | -0.04 | -0.05 | -0.05 |
| EPS Diluted Total Ops | -0.09 | -0.10 | -0.16 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -0.09 | -0.07 | -0.04 | -0.05 | -0.05 |
| EBITDA(a) | $-7,260 | $-5,340 | $-2,680 | $-2,980 | $-2,640 |